inner-banner-bg

Journal of Clinical & Experimental Immunology(JCEI)

ISSN: 2475-6296 | DOI: 10.33140/JCEI

Impact Factor: 1.9

Therapeutic Monoclonal Antibodies Approved by FDA in 2023

Citation

Henry Hongrong Cai

Cai, H, H., (2024). Therapeutic Monoclonal Antibodies Approved by FDA in 2023. J Clin Exp Immunol, 9(1), 01-02.

Abstract PDF